Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Gossamer Bio, Inc. (GOSS)
|
Add to portfolio |
|
|
|
| Price: |
$11.35
| | Metrics |
| OS: |
225.3
|
M
| |
|
|
| Market cap: |
$2.56
|
B
| |
|
|
|
Net cash:
|
$144
|
M
| |
$0.64
|
per share
|
|
EV:
|
$2.41
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
| Selling, general and administrative | | | | | | | -0.1 |
| Research and development | 170.9 | 170.3 | 160.9 | 143.4 | 55.3 | 0.9 | |
| General and administrative | 47.6 | 45.8 | 49.7 | 39.1 | 44.1 | 0.3 | |
| EBIT | -218.5 | -216.0 | -210.6 | -182.5 | -99.3 | -1.2 | -0.1 |
| Pre-tax income | -229.4 | -234.0 | -243.4 | -180.3 | -147.0 | 6.8 | -0.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -229.4 | -234.0 | -243.4 | -180.3 | -147.0 | -6.8 | -0.1 |
| |
| Diluted EPS | ($2.71) | ($3.13) | ($3.55) | ($3.29) | ($22.59) | ($0.74) | ($0.01) |
| Shares outstanding (diluted) | 84.6 | 74.8 | 68.5 | 54.7 | 6.5 | 9.2 | 9.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|